Premaitha Health (NIPT)


Latest News

Premaitha Health expands into Egyptian market

Prenatal testing group Premaitha Health said it had signed an agreement with a new partner to offer its test products in Eg...

Premaitha secures market entry into Egypt

RNS Number: 0580F Premaitha Health PLC 16 February 2018 Premaitha Health plc ("Premaitha" or the "Company") Premaitha secures market entry into Egypt Manchester, UK - 16 February 2018: Premaitha Health plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT"), announces that it has signed an...

Holding(s) in Company

RNS Number: 8716E Premaitha Health PLC 14 February 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Premaitha He...

Thermo Fisher - issue of warrants

RNS Number: 5161E Premaitha Health PLC 12 February 2018 Premaitha Health Plc ("Premaitha" or the "Company") Thermo Fisher - issue of warrants Manchester, UK - 12 February 2018 - Premaitha Health PLC (AIM: NIPT), a leading international molecular diagnostics group focused on prenatal testing, announces that further to the notification made 12 July 2017 ...

All News

16-02-18Premaitha Health expands into Egyptian marketStockMarketWire
16-02-18Premaitha secures market entry into EgyptRNS
14-02-18Holding(s) in CompanyRNS
12-02-18Thermo Fisher - issue of warrantsRNS
06-02-18Premaitha to attend key conferences in Middle EastRNS
05-02-18Premaitha Health gets regulatory nod in BrazilStockMarketWire
05-02-18Premaitha's IONA test approved for sale in BrazilRNS
24-01-18Premaitha Health gets right to appeal patent judgementStockMarketWire
24-01-18UK High Court grants right to appealRNS
22-01-18Premaitha Health sources loan for legal costsStockMarketWire
22-01-18Secured loan facility agreement with Thermo FisherRNS
29-12-17Premaitha Health grows half year revenue by 87%StockMarketWire
29-12-17Half Year ResultsRNS
11-12-17Premaitha Health adds laboratories in EuropeStockMarketWire
11-12-17Premaitha secures four further laboratories in EURNS
01-12-17Premaitha CEO Wins Outstanding Contribution AwardRNS
27-11-17Premaitha Health opening four new Middle East labsStockMarketWire
27-11-17Middle East laboratory network expansionRNS
23-11-17Premaitha signs NIPT partner in East AsiaStockMarketWire
23-11-17Premaitha signs new partner in East AsiaRNS
21-11-17Premaitha updates on patent disputesStockMarketWire
21-11-17Litigation First Instance JudgmentRNS
30-10-17Grant of Share OptionsRNS
24-10-17Result of AGMRNS
24-10-17Premaitha expects dispute ruling by year endStockMarketWire
24-10-17AGM StatementRNS
13-10-17Premaitha Health expands in Middle EastStockMarketWire
13-10-17Middle East UpdateRNS
29-09-17Final ResultsRNS
29-09-17Notice of AGMRNS
21-09-17Holding(s) in CompanyRNS
19-09-17Premaitha to offer NIPT in South AfricaRNS
07-09-17Further Patent Infringement ClaimsRNS
29-08-17Premaitha's Down's syndrome test approved in BrazilStockMarketWire
29-08-17Approved for Good Manufacturing Process in BrazilRNS
18-07-17Holding(s) in CompanyRNS
12-07-17Premaitha Health extends Thermo Fisher Scientific agreementStockMarketWire
12-07-17Investment Agreement Extension with Thermo FisherRNS
10-07-17Premaitha announces two laboratory hub contractsStockMarketWire
10-07-17Premaitha announces two laboratory hub contractsRNS

RSS feeds

  • Editorial news feed for LSE:NIPT Editorial
  • Regulatory news feed for LSE:NIPT Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account